Genentech`s Biologic Activase (Alteplase) Receives Approval in the U.S.
01 Sep 2022 //
FDA
Boehringer Ingelheim Focuses COVID-19 Clinical Research on Alteplase
26 Jul 2021 //
PRESS RELEASE
Boehringer Ingelheim Focuses COVID-19 Clinical Research on Alteplase
26 Jul 2021 //
PRESS RELEASE
Enforcement Report - Week of May 1, 2019
01 May 2019 //
FDA